CTCF Haploinsufficiency Destabilizes DNA Methylation and Predisposes to Cancer

Epigenetic alterations, particularly in DNA methylation, are ubiquitous in cancer, yet the molecular origins and the consequences of these alterations are poorly understood. CTCF, a DNA-binding protein that regulates higher-order chromatin organization, is frequently altered by hemizygous deletion o...

Full description

Bibliographic Details
Main Authors: Christopher J. Kemp, James M. Moore, Russell Moser, Brady Bernard, Matt Teater, Leslie E. Smith, Natalia A. Rabaia, Kay E. Gurley, Justin Guinney, Stephanie E. Busch, Rita Shaknovich, Victor V. Lobanenkov, Denny Liggitt, Ilya Shmulevich, Ari Melnick, Galina N. Filippova
Format: Article
Language:English
Published: Elsevier 2014-05-01
Series:Cell Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124714002915
_version_ 1818038183655374848
author Christopher J. Kemp
James M. Moore
Russell Moser
Brady Bernard
Matt Teater
Leslie E. Smith
Natalia A. Rabaia
Kay E. Gurley
Justin Guinney
Stephanie E. Busch
Rita Shaknovich
Victor V. Lobanenkov
Denny Liggitt
Ilya Shmulevich
Ari Melnick
Galina N. Filippova
author_facet Christopher J. Kemp
James M. Moore
Russell Moser
Brady Bernard
Matt Teater
Leslie E. Smith
Natalia A. Rabaia
Kay E. Gurley
Justin Guinney
Stephanie E. Busch
Rita Shaknovich
Victor V. Lobanenkov
Denny Liggitt
Ilya Shmulevich
Ari Melnick
Galina N. Filippova
author_sort Christopher J. Kemp
collection DOAJ
description Epigenetic alterations, particularly in DNA methylation, are ubiquitous in cancer, yet the molecular origins and the consequences of these alterations are poorly understood. CTCF, a DNA-binding protein that regulates higher-order chromatin organization, is frequently altered by hemizygous deletion or mutation in human cancer. To date, a causal role for CTCF in cancer has not been established. Here, we show that Ctcf hemizygous knockout mice are markedly susceptible to spontaneous, radiation-, and chemically induced cancer in a broad range of tissues. Ctcf+/− tumors are characterized by increased aggressiveness, including invasion, metastatic dissemination, and mixed epithelial/mesenchymal differentiation. Molecular analysis of Ctcf+/− tumors indicates that Ctcf is haploinsufficient for tumor suppression. Tissues with hemizygous loss of CTCF exhibit increased variability in CpG methylation genome wide. These findings establish CTCF as a prominent tumor-suppressor gene and point to CTCF-mediated epigenetic stability as a major barrier to neoplastic progression.
first_indexed 2024-12-10T07:38:41Z
format Article
id doaj.art-48463119a5594710b0d33483242f11b5
institution Directory Open Access Journal
issn 2211-1247
language English
last_indexed 2024-12-10T07:38:41Z
publishDate 2014-05-01
publisher Elsevier
record_format Article
series Cell Reports
spelling doaj.art-48463119a5594710b0d33483242f11b52022-12-22T01:57:22ZengElsevierCell Reports2211-12472014-05-01741020102910.1016/j.celrep.2014.04.004CTCF Haploinsufficiency Destabilizes DNA Methylation and Predisposes to CancerChristopher J. Kemp0James M. Moore1Russell Moser2Brady Bernard3Matt Teater4Leslie E. Smith5Natalia A. Rabaia6Kay E. Gurley7Justin Guinney8Stephanie E. Busch9Rita Shaknovich10Victor V. Lobanenkov11Denny Liggitt12Ilya Shmulevich13Ari Melnick14Galina N. Filippova15Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USADivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USADivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USAInstitute for Systems Biology, Seattle, WA 98106, USADivision of Hematology/Oncology, Weill Cornell Medical College, New York, NY 10021, USADivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USADivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USADivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USASage Bionetworks, 1100 Fairview Avenue, Seattle, WA 98109, USADivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USADivision of Hematology/Oncology, Weill Cornell Medical College, New York, NY 10021, USAMolecular Pathology Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, NIH, Rockville, MD 20852, USADepartment of Comparative Medicine, University of Washington, Seattle, WA 98195, USAInstitute for Systems Biology, Seattle, WA 98106, USADivision of Hematology/Oncology, Weill Cornell Medical College, New York, NY 10021, USADivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USAEpigenetic alterations, particularly in DNA methylation, are ubiquitous in cancer, yet the molecular origins and the consequences of these alterations are poorly understood. CTCF, a DNA-binding protein that regulates higher-order chromatin organization, is frequently altered by hemizygous deletion or mutation in human cancer. To date, a causal role for CTCF in cancer has not been established. Here, we show that Ctcf hemizygous knockout mice are markedly susceptible to spontaneous, radiation-, and chemically induced cancer in a broad range of tissues. Ctcf+/− tumors are characterized by increased aggressiveness, including invasion, metastatic dissemination, and mixed epithelial/mesenchymal differentiation. Molecular analysis of Ctcf+/− tumors indicates that Ctcf is haploinsufficient for tumor suppression. Tissues with hemizygous loss of CTCF exhibit increased variability in CpG methylation genome wide. These findings establish CTCF as a prominent tumor-suppressor gene and point to CTCF-mediated epigenetic stability as a major barrier to neoplastic progression.http://www.sciencedirect.com/science/article/pii/S2211124714002915
spellingShingle Christopher J. Kemp
James M. Moore
Russell Moser
Brady Bernard
Matt Teater
Leslie E. Smith
Natalia A. Rabaia
Kay E. Gurley
Justin Guinney
Stephanie E. Busch
Rita Shaknovich
Victor V. Lobanenkov
Denny Liggitt
Ilya Shmulevich
Ari Melnick
Galina N. Filippova
CTCF Haploinsufficiency Destabilizes DNA Methylation and Predisposes to Cancer
Cell Reports
title CTCF Haploinsufficiency Destabilizes DNA Methylation and Predisposes to Cancer
title_full CTCF Haploinsufficiency Destabilizes DNA Methylation and Predisposes to Cancer
title_fullStr CTCF Haploinsufficiency Destabilizes DNA Methylation and Predisposes to Cancer
title_full_unstemmed CTCF Haploinsufficiency Destabilizes DNA Methylation and Predisposes to Cancer
title_short CTCF Haploinsufficiency Destabilizes DNA Methylation and Predisposes to Cancer
title_sort ctcf haploinsufficiency destabilizes dna methylation and predisposes to cancer
url http://www.sciencedirect.com/science/article/pii/S2211124714002915
work_keys_str_mv AT christopherjkemp ctcfhaploinsufficiencydestabilizesdnamethylationandpredisposestocancer
AT jamesmmoore ctcfhaploinsufficiencydestabilizesdnamethylationandpredisposestocancer
AT russellmoser ctcfhaploinsufficiencydestabilizesdnamethylationandpredisposestocancer
AT bradybernard ctcfhaploinsufficiencydestabilizesdnamethylationandpredisposestocancer
AT mattteater ctcfhaploinsufficiencydestabilizesdnamethylationandpredisposestocancer
AT leslieesmith ctcfhaploinsufficiencydestabilizesdnamethylationandpredisposestocancer
AT nataliaarabaia ctcfhaploinsufficiencydestabilizesdnamethylationandpredisposestocancer
AT kayegurley ctcfhaploinsufficiencydestabilizesdnamethylationandpredisposestocancer
AT justinguinney ctcfhaploinsufficiencydestabilizesdnamethylationandpredisposestocancer
AT stephanieebusch ctcfhaploinsufficiencydestabilizesdnamethylationandpredisposestocancer
AT ritashaknovich ctcfhaploinsufficiencydestabilizesdnamethylationandpredisposestocancer
AT victorvlobanenkov ctcfhaploinsufficiencydestabilizesdnamethylationandpredisposestocancer
AT dennyliggitt ctcfhaploinsufficiencydestabilizesdnamethylationandpredisposestocancer
AT ilyashmulevich ctcfhaploinsufficiencydestabilizesdnamethylationandpredisposestocancer
AT arimelnick ctcfhaploinsufficiencydestabilizesdnamethylationandpredisposestocancer
AT galinanfilippova ctcfhaploinsufficiencydestabilizesdnamethylationandpredisposestocancer